Vitamin D status and mortality of German hemodialysis patients. 2012

Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
KfH Nephrological Center Moabit, Turmstr. 20A, 10559 Berlin, Germany. rolfdieter.krause@kfh-dialyse.de

OBJECTIVE The goal was to analyze the link between blood levels of calcidiol and all-cause, cardiac and infectious diseases, and mortality due to cancer in hemodialysis patients. METHODS This study retrospectively evaluated a representative sub-cohort (n=6,518) of German hemodialysis patients from the incidence cohorts 1997-2006. RESULTS Most (58.8%) were found to be vitamin D deficient (25(OH)D<20 ng/ml), with 41.2% being severely deficient (25(OH)D<12.5 ng/ml). All-cause mortality risk more than doubled in patients with severe deficiency (adjusted odds ratio (aOR)=2.67; 95% confidence interval (CI)=2.30-3.10; p<0.0001). Comparable data were obtained for mortality from cardiac disease (aOR=1.57; 95% CI=1.30-1.88; p<0.0001), infectious disease (aOR=1.48; 95% CI=1.15-1.90; p=0.0026), and cancer (aOR=1.51; 95% CI=1.09-2.08; p=0.0121), respectively. CONCLUSIONS These data highlight the need to ensure primarily adequate 25(OH)D levels in dialysis patients for an advantage of survival.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003141 Communicable Diseases An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host. Infectious Diseases,Communicable Disease,Disease, Communicable,Disease, Infectious,Diseases, Communicable,Diseases, Infectious,Infectious Disease
D005260 Female Females
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
October 2007, Kidney international,
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
August 2008, Kidney international,
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
February 2015, Anticancer research,
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
December 2014, Cardiorenal medicine,
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
November 2006, Kidney international,
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
October 2007, Kidney international,
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
January 2022, Computational and mathematical methods in medicine,
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
May 2020, Scientific reports,
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
November 2014, BMJ (Clinical research ed.),
Rolfdieter Krause, and Hans-Jürgen Schober-Halstenberg, and Günter Edenharter, and Kirsten Haas, and Heinz Jürgen Roth, and Ulrich Frei
September 2008, European journal of clinical nutrition,
Copied contents to your clipboard!